A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease.
Lists
Only you see this
Abstract
This study in non-diabetic CKD patients showed that Combination therapy with Aliskiren and ARB was effective but was not safe as it was associated with a high prevalence of hyperkalaemia.
BibTeX
@inproceedings{woo2013retrospective,
author = {Keng-Thye Woo and Hui‐Lin Choong and Kok‐Seng Wong and Han-Kim Tan and Marjorie Foo and Fook-Chong Stephanie and Evan Jc Lee and Anantharaman Vathsala and Grace Sl Lee and Choong-Meng Chan},
title = {{A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease.}},
booktitle = {PubMed},
year = {2013},
doi = {10.5527/wjn.v2.i4.129},
}Loading related content...